From the aWHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
bMRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom
cNIHR Health Protection Research Unit in Behavioural Science and Evaluation, University of Bristol, Bristol, United Kingdom
dLaboratory of Data Discovery for Health Limited, Hong Kong Science Park, New Territories, Hong Kong.
Submitted May 19, 2022; accepted November 7, 2022
This project was supported by the Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (grant no. COVID190118), the Collaborative Research Fund (Project No. CID-HKU2-10), and the general research fund (Project No. 17110221) of the Research Grants Council of the Hong Kong SAR Government. B.J.C. was supported by the [email protected] program of the Innovation and Technology Commission of the Hong Kong SAR Government.
Disclosure: B.J.C. reports honoraria from AstraZeneca, GSK, Moderna, Roche and Sanofi Pasteur. The other authors report no conflicts of interest.
Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).
Data on the incidence of coronavirus disease 2019 is freely available from the Hong Kong government data website (https://data.gov.hk/en/). Computing code for this analysis could be retrieved from GitHub.
Correspondence: Tim K. Tsang, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 7 Sassoon Road, Pokfulam, Hong Kong. E-mail: [email protected].
